{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:50:22Z","timestamp":1746766222915,"version":"3.32.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T00:00:00Z","timestamp":1728777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.conctc.2024.101382","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T10:58:05Z","timestamp":1728989885000},"page":"101382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Run-in periods and treatment outcomes in asthma trials: A narrative review"],"prefix":"10.1016","volume":"42","author":[{"given":"Emilio","family":"Pizzichini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Brusselle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huib A.","family":"Kerstjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Slade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.conctc.2024.101382_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"issue":"7303","key":"10.1016\/j.conctc.2024.101382_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.conctc.2024.101382_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/CLEP.S188752","article-title":"Randomized clinical trials with run-in periods: frequency, characteristics and reporting","volume":"11","author":"Laursen","year":"2019","journal-title":"Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.conctc.2024.101382_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2020.6463","article-title":"Use of run-in periods in randomized trials","volume":"324","author":"Huo","year":"2020","journal-title":"JAMA"},{"issue":"10210","key":"10.1016\/j.conctc.2024.101382_bib8","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(19)32215-9","article-title":"Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials","volume":"394","author":"Virchow","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.conctc.2024.101382_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"10","key":"10.1016\/j.conctc.2024.101382_bib10","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S2213-2600(20)30190-9","article-title":"Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study","volume":"8","author":"Kerstjens","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"13","key":"10.1016\/j.conctc.2024.101382_bib11","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.conctc.2024.101382_bib12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1183\/09031936.93.03101122","article-title":"Long-term effects of budesonide on airway responsiveness and clinical asthma severity in inhaled steroid-dependent asthmatics","volume":"3","author":"Juniper","year":"1990","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.conctc.2024.101382_bib13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/ph3030514","article-title":"Inhaled corticosteroids","volume":"3","author":"Barnes","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.conctc.2024.101382_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1513\/AnnalsATS.201510-712PS","article-title":"Tiotropium respimat is effective for the treatment of asthma at a dose lower than that for chronic obstructive pulmonary disease","volume":"13","author":"Chin","year":"2016","journal-title":"Annals of the American Thoracic Society"},{"issue":"2","key":"10.1016\/j.conctc.2024.101382_bib15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jaci.2011.04.039","article-title":"Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial","volume":"128","author":"Kerstjens","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.conctc.2024.101382_bib16","unstructured":"Boehringer IngeBoehringer Ingelheim Pharmaceuticals IlP, Inc. SPIRIVA\u00ae RESPIMAT\u00ae (Tiotropium Bromide Inhalation Spray), for Oral Inhalation Use [packing Insert on the Internet]. 2004 [updated Nov 2021; cited 2023 Feb 22]."},{"key":"10.1016\/j.conctc.2024.101382_bib17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.rmed.2016.06.013","article-title":"Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status","volume":"117","author":"Kerstjens","year":"2016","journal-title":"Respir. Med."},{"issue":"10109","key":"10.1016\/j.conctc.2024.101382_bib18","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/S0140-6736(17)32397-8","article-title":"Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial","volume":"390","author":"Woodcock","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.conctc.2024.101382_bib19","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s12325-019-01192-1","article-title":"Real-world data and randomised controlled trials: the Salford lung study","volume":"37","author":"Leather","year":"2020","journal-title":"Adv. Ther."},{"issue":"10118","key":"10.1016\/j.conctc.2024.101382_bib20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865424001297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865424001297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T05:00:11Z","timestamp":1735102811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865424001297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":17,"alternative-id":["S2451865424001297"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2024.101382","relation":{},"ISSN":["2451-8654"],"issn-type":[{"type":"print","value":"2451-8654"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Run-in periods and treatment outcomes in asthma trials: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2024.101382","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101382"}}